Ligand Pharmaceuticals LGND Balance Sheet

Income Statement

Quarter End	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	1.3B	1.11B	1.08B	1.05B	762.67M	811.08M	758.11M	769.23M
Total Current Assets	464.75M	276.07M	243.78M	220.43M	263.6M	328.2M	276.71M	253.99M
Cash and Equivalents	19.52M	14.99M	5.28M	4.12M	45.01M	88.73M	28.45M	19.28M
Total Non-Current Assets	837.14M	813.5M	817.47M	815.73M	507.45M	478.94M	477.63M	511.67M
Total Liabilities	476.43M	311.99M	273.92M	234.31M	165.18M	164.76M	93.21M	101.33M
Total Current Liabilities	41.67M	42.58M	167.85M	135.24M	98.81M	98.93M	29.39M	15.73M
Total Non-Current Liabilities	755.54M	445.95M	106.07M	99.07M	66.38M	65.83M	63.83M	85.6M
Common Equity	17k	17k	17k	17k	17k	17k	17k	18k
Retained Earnings	449.09M	468.84M	467.94M	468.35M	450.86M	492.81M	495.1M	484.83M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	601.59M	671.02M	1.26B	1.49B	1.36B	1.3B	762.67M	787.22M
Total Current Assets	163.05M	237.02M	870.54M	1.12B	500.56M	464.75M	263.6M	237.43M
Cash and Equivalents	18.75M	20.62M	117.16M	71.54M	47.62M	19.52M	45.01M	22.95M
Total Non-Current Assets	341.29M	399.79M	560.91M	767.23M	709.53M	821.16M	597.49M	700.91M
Total Liabilities	260.3M	271.23M	699.89M	727.68M	652.76M	476.43M	165.18M	86.3M
Total Current Liabilities	227.13M	238.87M	82.25M	17M	100.11M	41.67M	98.81M	16.78M
Total Non-Current Liabilities	33.17M	32.37M	1.23B	1.35B	995.05M	755.54M	66.38M	69.54M
Total Equity	341.29M	399.79M	560.91M	767.23M	709.53M	821.16M	597.49M	700.91M
Common Equity	21k	21k	21k	17k	16k	17k	17k	18k
Retained Earnings	-431.13M	-400.92M	-229.2M	400.11M	391.95M	449.09M	450.86M	503.02M